AutoGenomics Invited to Present at the JPMorgan Healthcare ... ( CARLSBAD Calif. Jan. 4 /- AutoGen...)

AutoGenomics Invited to Present at the JPMorgan Healthcare Conference

Date:1/4/2008

CARLSBAD, Calif., Jan. 4 /PRNewswire/ -- AutoGenomics announced today that the Company has been invited and has accepted to present at the JPMorgan Healthcare Conference, which is being held January 7-10, 2008 at the Westin St. Francis Hotel in San Francisco, CA. At this conference, Fareed Kureshy President and Chief Executive Officer will provide an overview of the Company at 4.30 PM on Tuesday, January 8, 2008.

About JPMorgan 26th Annual Healthcare Conference

JPMorgan's premier annual conference on the healthcare industry will feature more than 300 public and private companies over four days of simultaneous sessions.

About AutoGenomics

AutoGenomics Inc., a privately held company based in Carlsbad, CA, has developed the first automated, microarray based multiplexing diagnostic platform that can be used to assess disease signatures with novel genomic and proteomic markers in the area of genetic disorders, infectious disease, cancer and pharmacogenetics. With the discovery of genes and their link to various disease states the platform has the versatility to revolutionize the way patients are diagnosed, monitored and managed leading to the era of personalized medicine. http://www.autogenomics.com

0

GOOD

Page: 1
Related biology technology :

1. Genstruct CEO, Dr. Keith Elliston, Invited to Speak at Oncology Clinical Trial Summit
2. Arpida Invited to Present Preclinical Data on Novel Topical Antibiotic AR-2474 at ICAAC
3. Pharsight Invited to Present on Winning Strategies for R&D Productivity at New York Pharma Forum on October 15, 2007
4. Pharsight Invited to Present on Oncology Modeling and Simulation at Quantitative Pharmacology Symposium in China
5. Imagenetix Inc. to Present at Noble Small Cap Financial Conference on August 21, 2007
6. Avicena Group to Present at Noble Financial Conference
7. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
8. Strategic Diagnostics to Present at Two Upcoming Investor Conferences
9. Intellect Neurosciences, Inc. to Present Data on Alzheimers Vaccine at 13th International Congress of Immunology Conference
10. CEL-SCI to Present at the Noble Financial Conference
11. Lexicon Presents Class of Compounds Modulating TPH1, the Target for its LX1031 Investigational Drug for Irritable Bowel Syndrome

Post Your Comments:

AutoGenomics Invited to Present at the JPMorgan Healthcare ...( CARLSBAD Calif. Jan. 4 /- AutoGen...)